Anjie L.
About Anjie L.
Anjie L. is the Co-Founder and CEO of Kiwi Biosciences, a company focused on developing enzyme solutions for dietary supplements and foods aimed at individuals with IBS. She studied at Harvard University and Y Combinator, and has a background in innovation and entrepreneurship.
Work at Kiwi Biosciences
Anjie L. serves as the Co-Founder and CEO of Kiwi Biosciences, a company established in 2020 and based in Cambridge, Massachusetts. The company specializes in developing patent-pending enzyme solutions aimed at enhancing dietary supplements and food products. Kiwi Biosciences focuses on creating innovative solutions for individuals with Irritable Bowel Syndrome (IBS), a condition affecting 10-15% of the population. Under Anjie's leadership, the company has developed Fodzyme, a product designed to integrate novel enzymes into everyday foods, making food consumption easier for those affected by IBS.
Education and Expertise
Anjie L. has a diverse educational background. She studied at Harvard University from 2013 to 2017, where she earned a Bachelor of Arts degree with a focus on Physics and Comparative Literature. Prior to her time at Harvard, she completed her high school education at New Hartford Senior High School from 2009 to 2013. Additionally, Anjie participated in the Y Combinator Summer 2021 Batch, an intensive three-month program designed to support startups and entrepreneurs. Her academic and entrepreneurial experiences contribute to her expertise in innovation and business development.
Background
Anjie L. has a background that includes significant research experience. In 2015, she worked as a Student Researcher at CERN for three months, where she engaged in advanced scientific research. This experience, combined with her education at Harvard, has equipped her with a strong foundation in both the sciences and the humanities. Anjie's journey reflects a commitment to innovation and entrepreneurship, culminating in her role at Kiwi Biosciences.
Achievements
Anjie L. has been recognized for her contributions to the field of entrepreneurship and innovation. She was featured in Forbes 30 Under 30, highlighting her impact and potential in the business landscape. This acknowledgment reflects her achievements in founding and leading Kiwi Biosciences, as well as her commitment to addressing the needs of individuals with IBS through innovative dietary solutions.